XML 85 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Unvested Share Activity
Ordinary Shares
A summary of the changes in the Company’s unvested ordinary shares during the year ended December 31, 2022, 2021 and 2020 are as follows:
Number of SharesWeighted Average Grant Date Fair Value
Unvested and Outstanding as of December 31, 202013,757 $2.36 
Granted— $— 
Vested(13,757)$2.36 
Forfeited— $— 
Unvested and Outstanding as of December 31, 2022 and 2021— $— 
Schedule of Nonvested Restricted Share Units Activity
A summary of the changes in the Company’s unvested restricted share units during the years ended December 31, 2022, 2021 and 2020 are as follows:
Number of SharesWeighted Average Grant Date Fair Value
Unvested and Outstanding as of December 31, 2020217,482 $10.19 
Granted— — 
Vested(70,482)10.19 
Forfeited(31,860)10.19 
Unvested and Outstanding as of December 31, 2021115,140 $10.19 
Granted202,830 13.52 
Vested(42,635)9.77 
Forfeited(4,200)14.44 
Unvested and Outstanding as of December 31, 2022
271,135 $12.23 
Schedule of Share-based Payment Arrangement, Option Activity
The following table summarizes the Company’s share options activity for the years ended December 31, 2022, 2021 and 2020:
Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 20204,430,340 $5.61 9.22$186,426 
Granted1,043,702 $36.11 
Exercised(1,244,709)$1.55 
Cancelled or forfeited(313,830)$22.45 
Outstanding as of December 31, 2021
3,915,503 $13.53 8.64$51,162 
Granted2,120,783 $13.49 
Exercised(462,722)$0.75 
Cancelled or forfeited(480,832)$11.09 
Outstanding as of December 31, 2022
5,092,732 $13.55 8.38$13,013 
Exercisable as of December 31, 2022
2,342,389 $9.14 7.67$11,765 
Unvested as of December 31, 2022
2,750,343 $17.31 8.99$1,247 
Schedule of Valuation Assumptions
The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the share options granted to employees and directors during the years ended December 31, 2022, 2021 and 2020 were as follows:
Year Ended December 31,
202220212020
Expected option life (years)5.95 years5.73 years5.95 years
Expected volatility80.76 %67.36 %66.10 %
Risk-free interest rate2.26 %0.95 %0.43 %
Expected dividend yield— %— %— %
Fair value of underlying ordinary shares$14.06 $35.21 $12.58 
Summary of Share-based Compensation Expense
Share-based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):
Year Ended December 31,
202220212020
Research and development7,3584,5696,336
General and administrative5,7654,07011,647
Total stock based compensation expense$13,123 $8,639 $17,983